<DOC>
	<DOCNO>NCT01061320</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy alpha tocopherol prevention contrast-induced nephropathy CKD patient undergo elective coronary procedure .</brief_summary>
	<brief_title>Efficacy Alpha Tocopherol Prevention Contrast-induced Nephropathy Chronic Kidney Disease ( CKD ) Patients</brief_title>
	<detailed_description>Contrast-induced nephropathy ( CIN ) increase likelihood patient morbidity mortality follow coronary procedure . Contrast agent cause acute deterioration renal function via generation reactive oxygen specie . Vitamin E ( alpha tocopherol ) demonstrate anti-oxidant anti-inflammation . The present study design evaluate administration antioxidant vitamin E ( alpha tocopherol ) mean prevent CIN patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>serum creatinine level &gt; 1.2 mg/dL baseline creatinine clearance level &lt; 60 mL/min ( measure recent sample , drawn within 2 month prior begin study ) patient acute kidney injury end stage renal disease ( require dialysis ) unstable renal function ( evidenced change serum creatinine &gt; 0.5 mg/dL , &gt; 25 % , within 14 day prior study ) allergy contrast agent mechanical ventilation suffer congestive heart failure , cardiogenic shock emergent angiography . receive NAC , mannitol , diuretic , theophylline , dopamine , vitamin E contrast agent within 14 day study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Alpha-Tocopherol ( Vitamin E )</keyword>
	<keyword>Contrast induce nephropathy</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Coronary procedure</keyword>
</DOC>